IMUGENE LIMITED
Who is IMUGENE LIMITED?
Imugene is a clinical stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Our unique platform technologies seek to harness the body’s immune system against tumours, potentially ach...See more
Industry & Specialities
Others
Countries of Operation
Australia New Zealand
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
51-200 Employees
Year Founded:
2013 (13 years)
Address:
37 BLIGH ST; SUITE 1006, LEVEL 10; SYDNEY, NEW SOUTH WALES 2000, AU
Employees by Department
- The Rest (5)
- Total (5)
Key Decision Makers
Nimali Withana
Senior Director of Clinical Science
Bonnie Nixon
Senior Clinical Trial Manager
Leslie Chong
Chief Executive Officer & Managing Director
Johannes Frederik Van Aswegen Sa
Finance Manager
Insight
Signals
At a glance- Operates in multiple countries
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Employees by Seniority
C-level
1employees
Senior
2employees
Non-managers
0employees
Financials
HIGH
spending power
Funding Status
Publicly listed on stock exchange
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has IMUGENE LIMITED been operating for?
- What is the funding status of IMUGENE LIMITED?
- Where is IMUGENE LIMITED's headquarter?
- What IMUGENE LIMITED's spending power?
- Does IMUGENE LIMITED have a presence in the domain it operates in?